Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-886
Closed -$201K – 892
2023
Q4
$201K Buy
+886
New +$186K ﹤0.01% 773
2023
Q2
– Sell
-1,037
Closed -$204K – 969
2023
Q1
$204K Sell
1,037
-214
-17% -$44K ﹤0.01% 876
2022
Q4
$253K Buy
+1,251
New +$244K ﹤0.01% 814
2022
Q3
– Sell
-1,050
Closed -$211K – 1007
2022
Q2
$211K Sell
1,050
-823
-44% -$175K ﹤0.01% 664
2022
Q1
$425K Buy
1,873
+268
+17% +$63K 0.01% 478
2021
Q4
$434K Buy
1,605
+244
+18% +$60.4K 0.01% 482
2021
Q3
$329K Buy
1,361
+515
+61% +$130K ﹤0.01% 744
2021
Q2
$200K Buy
+846
New +$193K ﹤0.01% 895
2017
Q1
– Sell
-1,886
Closed -$208K – 501
2016
Q4
$208K Hold
1,886
– – 0.01% 464
2016
Q3
$223K Buy
+1,886
New +$222K 0.01% 489

Other funds holding LH

SVB Wealth's LH Position: Q1 2024 in Review

SVB Wealth sold out of Labcorp (LH) in Q1 2024, closing a stake of 886 shares — an estimated $201K sold.

SVB Wealth first reported a position in LH in Q3 2016 and held it in 10 quarters. The position peaked at $434K in Q4 2021. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • SVB Wealth reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • SVB Wealth sold 886 Labcorp shares in Q1 2024, an estimated $201K.
  • SVB Wealth first reported a position in Labcorp in Q3 2016 and held it in 10 quarters.
  • SVB Wealth's Labcorp position peaked at $434K in Q4 2021.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on SVB Wealth's 13F filing for Q1 2024, filed 15 May 2024.